Tetsusuke Yoshimoto
Overview
Explore the profile of Tetsusuke Yoshimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sakakibara N, Higashi T, Yamashita I, Yoshimoto T, Matoba M
BMC Palliat Care
. 2018 Aug;
17(1):102.
PMID: 30143039
Background: The Pain Management Index (PMI) is widely used in the assessment of pain management, and negative scores are traditionally considered to indicate inadequate pain management. However, it is not...
2.
Yoshimoto T, Ryu E, Tomiyasu S, Hojo M, Kokubun H, Matoba M
Biol Pharm Bull
. 2018 Mar;
41(6):850-857.
PMID: 29526884
Pure oxycodone injection became increasingly necessary after oral oxycodone was launched in Japan in 2003. However, trials clarifying the efficacy and safety of injection are rare. Therefore, a multicenter open...
3.
Yoshimoto T, Tomiyasu S, Saeki T, Tamaki T, Hashizume T, Murakami M, et al.
Am J Hosp Palliat Care
. 2015 Oct;
34(1):92-99.
PMID: 26443717
It has been reported that pain relief for patients with cancer is suboptimal in Japan. This has been mainly attributed to inadequate dissemination of the World Health Organization (WHO) guidelines...
4.
Iwamoto M, Higashi T, Miura H, Kawaguchi T, Tanaka S, Yamashita I, et al.
Jpn J Clin Oncol
. 2015 Sep;
45(11):1036-41.
PMID: 26358712
Objective: The state of opioid consumption among cancer patients has never been comprehensively investigated in Japan. The Diagnosis Procedure Combination claims data may be used to measure and monitor opioid...
5.
Takigawa C, Goto F, Tanda S, Shima Y, Yomiya K, Matoba M, et al.
Jpn J Clin Oncol
. 2014 Nov;
45(1):67-74.
PMID: 25381384
Objective: Rapid analgesic onset opioids, particularly fentanyl buccal tablet, is preferable for managing breakthrough pain. The efficacy and safety of fentanyl buccal tablet and its association with around-the-clock opioids needs...
6.
Kokubun H, Yoshimoto T, Hojo M, Fukumura K, Matoba M
J Pain Palliat Care Pharmacother
. 2014 Nov;
28(4):338-50.
PMID: 25359452
ABSTRACT In Japan, Oxycodone hydrochloride injection formulation has been approved in 2012. However, its pharmacokinetics has been poorly studied. The aim of this study is to evaluate the pharmacokinetics of...
7.
Kosugi T, Hamada S, Takigawa C, Shinozaki K, Kunikane H, Goto F, et al.
J Pain Symptom Manage
. 2013 Oct;
47(6):990-1000.
PMID: 24099893
Context: Rapid-onset opioids for treating breakthrough pain (BTP) in patients with cancer are needed in the Japanese care setting. Objectives: To examine the efficacy and safety of fentanyl buccal tablets...
8.
Higashi T, Yoshimoto T, Matoba M
Glob J Health Sci
. 2012 Nov;
4(6):197-203.
PMID: 23121757
Objectives: To promote effective management of cancer pain as a nationwide health policy, it is necessary to monitor the performance of health care providers in managing pain in their patients....
9.
Yoshimoto T, Hisada A, Yomiya K, Tomiyasu S, Hasegawa T, Murakami S, et al.
Gan To Kagaku Ryoho
. 2010 May;
37(5):871-8.
PMID: 20495318
Oral oxycodone has been available since 2003 in Japan. Oxycodone consumption is increasing along with the decrease in morphine consumption. Although this drug currently has a central role in cancer...
10.
Yoshimoto T, Hisada A, Hasegawa T, Nozaki Y, Matoba M
Gan To Kagaku Ryoho
. 2009 Oct;
36(10):1683-9.
PMID: 19838028
The compound oxycodone injection, but not pure oxycodone, has been available since the 1920's in Japan. The compound, containing oxycodone and hydrocotarnine, can be subcutaneously administered. Hydrocotarnine is a non-narcotic...